Transcriptomics

Dataset Information

0

E-MTAB-6485

ABSTRACT: RNA-seq to investigate impact of treatment of KRAS mutant NCI-H358 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib

PROVIDER: E-MTAB-6485 | ExpressionAtlas | 2019-05-14

REPOSITORIES: ExpressionAtlas

Json Xml

Similar Datasets

Transcriptomics E-MTAB-6486
2019-05-14 | E-MTAB-6486 | ExpressionAtlas
Genomics RNA-seq to investigate impact of treatment of KRAS mutant NCI-H2009 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib
| PRJEB24901 | ENA
Genomics RNA-seq to investigate impact of treatment of KRAS mutant NCI-H358 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib
| PRJEB24900 | ENA
Transcriptomics E-MTAB-6483
2019-05-14 | E-MTAB-6483 | ExpressionAtlas
Transcriptomics RNA-seq to investigate impact of treatment of KRAS mutant A549 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib
2018-06-01 | E-MTAB-6483 | biostudies-arrayexpress
Transcriptomics RNA-seq to investigate impact of treatment of KRAS mutant NCI-H2009 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib
2018-06-01 | E-MTAB-6486 | biostudies-arrayexpress
Transcriptomics RNA-seq to investigate impact of treatment of KRAS mutant NCI-H358 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib
2018-06-01 | E-MTAB-6485 | biostudies-arrayexpress
Genomics RNA-seq to investigate impact of treatment of KRAS mutant A549 lung adenocarcinoma cells with the multi-ERBB inhibitor Neratinib
| PRJEB24899 | ENA
Unknown Epithelial-to-mesenchymal transition defines feedback activation of receptor tyrosine kinase signaling induced by MEK inhibition in KRAS mutant lung cancer
2017-03-15 | GSE79235 | GEO
Unknown Human lung adenocarcinoma NCI-H1975 cells: parental vs cell lines resistant to the EGFR-TK inhibitor CNX-2006
2015-07-01 | GSE53234 | GEO